FH and atypical hemolytic-uremic syndrome: Genetic variation and/or acquired autoantibodies are the two major factors that impair FH function, and therefore are the primary drivers of two complement-mediated renal diseases, atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G).